Orforglipron in Delaware (2026)
orforglipron · GLP-1 weight management · Delaware-specific guide
About Orforglipron
First once-daily oral non-peptide GLP-1. Brand-only, launching via LillyDirect at $149/month. No injection, no compounded versions.
See the full Orforglipron review for dosing, efficacy data, side effects, and the full pharmacy + telehealth program comparison.
Insurance coverage for Orforglipron in Delaware
Delaware Medicaid coverage varies by plan and indication. Diabetes coverage is generally available with prior authorization.
Carrier-level coverage data for Orforglipron is not yet tracked in our database for $Delaware. Check your specific plan's formulary or our insurance hub.
Telehealth and prescribing in Delaware
Delaware permits interstate telehealth prescribing with state-licensed clinicians.
Major platforms with active Delaware availability that may prescribe Orforglipron: Ro Body, Hims Weight Loss, Sequence (Weight Watchers). Each platform varies in which drugs they prescribe, insurance handling, and clinical model. See our platform comparisons for details.
Compounded Orforglipron in Delaware
Delaware Board of Pharmacy is following FDA April 2026 enforcement guidance.
See our guide on the FDA compounding shutdown for the national context.
Orforglipron in Delaware — frequently asked
Is Orforglipron legal in Delaware?+
Yes. Orforglipron (orforglipron) is FDA-approved and legal in all 50 US states including Delaware. State-level differences appear in insurance coverage, telehealth prescribing rules, and (for GLP-1s) compounding pharmacy access — not in the underlying legality of the medication itself.
Can I get Orforglipron via telehealth in Delaware?+
Delaware permits interstate telehealth prescribing with state-licensed clinicians. Major US telehealth platforms operating in Delaware that may prescribe Orforglipron include Ro Body, Hims Weight Loss, Sequence (Weight Watchers). Each platform handles insurance and prescribing differently — see our platform comparisons for details.
Does Delaware Medicaid cover Orforglipron?+
Delaware Medicaid coverage varies by plan and indication. Diabetes coverage is generally available with prior authorization. For Orforglipron specifically: Medicaid coverage of GLP-1s for weight loss varies dramatically by state and indication. Diabetes indications are easier to get covered than weight-loss-only indications.
What's the cheapest way to get Orforglipron in Delaware?+
For Orforglipron in Delaware, the three main paths are: (1) insurance with prior authorization if your plan covers it (often $0-$25 copay), (2) manufacturer self-pay programs (NovoCare for Wegovy/Ozempic, LillyDirect for Zepbound/Mounjaro/Orforglipron), (3) telehealth bundles that include the medication. Direct-pay manufacturer programs typically beat retail pharmacy prices in 2026.
Is compounded Orforglipron still available in Delaware?+
Delaware Board of Pharmacy is following FDA April 2026 enforcement guidance. The FDA proposed permanently ending large-scale 503B compounding of semaglutide and tirzepatide on April 30, 2026. Individualized 503A compounding for documented clinical need may continue in Delaware, but routine 'cheaper alternative' compounding is being shut down.